Efficacy and safety of secukinumab in patients with generalized pustular psoriasis: A 52-week analysis from phase III open-label multicenter Japanese study-Reference-Cited by-同舟云学术

Efficacy and safety of secukinumab in patients with generalized pustular psoriasis: A 52-week analysis from phase III open-label multicenter Japanese study

Published:2016-02-26 Issue:9 Volume:43 Page:1011-1017
ISSN:0385-2407
Container-title:The Journal of Dermatology
language:en
Short-container-title:J Dermatol

Author:

Imafuku Shinichi¹,Honma Masaru²,Okubo Yukari³,Komine Mayumi⁴,Ohtsuki Mamitaro⁴,Morita Akimichi⁵,Seko Noriko⁶,Kawashima Naoko⁷,Ito Saori⁸,Shima Tomohiro⁹,Nakagawa Hidemi¹⁰

Affiliation:

1. Department of Dermatology; Fukuoka University; Fukuoka Japan

2. Department of Dermatology; Asahikawa Medical University; Asahikawa Japan

3. Department of Dermatology; Tokyo Medical University; Tokyo Japan

4. Department of Dermatology; Jichi Medical University; Shimotsuke Japan

5. Department of Dermatology; Nagoya City University; Nagoya Japan

6. Department of Biometrics and Statistical Sciences; Novartis Pharma K.K.; Tokyo Japan

7. Clinical Trial Management Group; Novartis Pharma K.K.; Tokyo Japan

8. Department of Clinical Resource and Development; Novartis Pharma K.K.; Tokyo Japan

9. Department of Immunology and Dermatology Clinical Franchise; Novartis Pharma K.K.; Tokyo Japan

10. Department of Dermatology; The Jikei University School of Medicine; Tokyo Japan

Funder

Novartis Pharmaceuticals

Publisher

Wiley

Subject

Dermatology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/1346-8138.13306/fullpdf

Reference13 articles.

1. Treatment of two patients with generalized pustular psoriasis with the interleukin-1β inhibitor gevokizumab;Mansouri;Br J Dermatol,2015

2. The majority of generalized pustular psoriasis without psoriasis vulgaris is caused by deficiency of interleukin-36 receptor antagonist;Sugiura;J Invest Dermatol,2013

3. Analysis of psoriasis patients registered with the Japanese Society for Psoriasis Research from 2002-2008;Takahashi;J Dermatol,2011

4. Psoriasis;Nestle;N Engl J Med,2009

5. Japanese Dermatological Association 2015 Japanese Dermatological Guidelines for General Pustular Psoriasis https://www.dermatol.or.jp/uploads/uploads/files/guideline/1372913421_3.pdf

Cited by 159 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Treatments for Generalized Pustular Psoriasis: A Narrative Summary of a Systematic Literature Search;Dermatology and Therapy;2024-08-01

2. Relapsing polychondritis associated with pustular psoriasis successfully treated with secukinumab: a case-based review;Egyptian Rheumatology and Rehabilitation;2024-07-01

3. Review of Generalized Pustular Psoriasis: Prevalence, Diagnosis, and Treatment Options;Journal of Psoriasis and Psoriatic Arthritis;2024-06-07

4. Safety and effectiveness of guselkumab in Japanese patients with psoriasis: 20‐week interim analysis of a postmarketing surveillance study;The Journal of Dermatology;2024-05-15

5. Use of biologics in Chinese pregnant patients with deficiency of interleukin-36 receptor antagonist (DITRA): A case series;Taiwanese Journal of Obstetrics and Gynecology;2024-05